Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VA106483 in Male Subjects With Nocturia
NCT01038843Phase 2Completed
- Sponsor
- Vantia Therapeutics
- Start
- Dec 2009
- Primary completion
- Jul 2010
- Countries
- 1
01
Overview
A Phase 2 trial of fedovapagon in nocturia, sponsored by Vantia Therapeutics. Started Dec 2009; status: completed.
02
Drugs
fedovapagon
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT01038843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038843.